Literature DB >> 21488979

Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Alexander R C Wong1, Jaclyn S Pearson, Michael D Bright, Diana Munera, Keith S Robinson, Sau Fung Lee, Gad Frankel, Elizabeth L Hartland.   

Abstract

The human pathogens enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) share a unique mechanism of colonization that results from the concerted action of effector proteins translocated into the host cell by a type III secretion system (T3SS). EPEC and EHEC not only induce characteristic attaching and effacing (A/E) lesions, but also subvert multiple host cell signalling pathways during infection. Our understanding of the mechanisms by which A/E pathogens hijack host cell signalling has advanced dramatically in recent months with the identification of novel activities for many effectors. In addition to further characterization of established effectors (Tir, EspH and Map), new effectors have emerged as important mediators of virulence through activities such as mimicry of Rho guanine nucleotide exchange factors (Map and EspM), inhibition of apoptosis (NleH and NleD), interference with inflammatory signalling pathways (NleB, NleC, NleE and NleH) and phagocytosis (EspF, EspH and EspJ). The findings have highlighted the multifunctional nature of the effectors and their ability to participate in redundant, synergistic or antagonistic relationships, acting in a co-ordinated spatial and temporal manner on different host organelles and cellular pathways during infection.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488979     DOI: 10.1111/j.1365-2958.2011.07661.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  169 in total

1.  Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Authors:  Wanyin Deng; Hong B Yu; Carmen L de Hoog; Nikolay Stoynov; Yuling Li; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2012-06-01       Impact factor: 5.911

2.  Genetic diversity of locus of enterocyte effacement genes of enteropathogenic Escherichia coli isolated from Peruvian children.

Authors:  C A Contreras; T J Ochoa; J Ruiz; D W Lacher; D Durand; C DebRoy; C F Lanata; T G Cleary
Journal:  J Med Microbiol       Date:  2012-04-05       Impact factor: 2.472

3.  Genetic background and mobility of variants of the gene nleA in attaching and effacing Escherichia coli.

Authors:  Kristina Creuzburg; Sabine Heeren; Claudia M Lis; Markus Kranz; Michael Hensel; Herbert Schmidt
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

4.  Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics.

Authors:  Dapeng Zhang; Robson F de Souza; Vivek Anantharaman; Lakshminarayan M Iyer; L Aravind
Journal:  Biol Direct       Date:  2012-06-25       Impact factor: 4.540

5.  Identification and regulation of a novel Citrobacter rodentium gut colonization fimbria (Gcf).

Authors:  Gustavo G Caballero-Flores; Matthew A Croxen; Verónica I Martínez-Santos; B Brett Finlay; José L Puente
Journal:  J Bacteriol       Date:  2015-02-09       Impact factor: 3.490

6.  Intracellular d-Serine Accumulation Promotes Genetic Diversity via Modulated Induction of RecA in Enterohemorrhagic Escherichia coli.

Authors:  James P R Connolly; Andrew J Roe
Journal:  J Bacteriol       Date:  2016-11-18       Impact factor: 3.490

Review 7.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Authors:  Stuart W Hicks; Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2013-05       Impact factor: 60.633

Review 9.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  The enteropathogenic Escherichia coli-secreted protein EspZ inhibits host cell apoptosis.

Authors:  Jennifer Lising Roxas; John Scott Wilbur; Xiangfeng Zhang; Giovanna Martinez; Gayatri Vedantam; V K Viswanathan
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.